Obtenez 3 mois à 0,99 $/mois

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de Blood Podcast

Blood Podcast

Blood Podcast

Auteur(s): American Society of Hematology
Écouter gratuitement

À propos de cet audio

The Blood Podcast summarizes content recently published in Blood, the most cited peer-reviewed publication in the field of hematology.© 2025 American Society of Hematology Hygiène et mode de vie sain Science Troubles et maladies
Épisodes
  • Review Series on Platelet Heterogeneity
    Dec 11 2025

    In this Review Series episode, Blood Associate Editor, Dr. Elisabeth Battinelli discusses the Platelet Heterogeneity with authors Drs. Craig Morrell, Larry Frelinger, and Leo Nicolai.

    Find the full review series in volume 146 issue 24 of Blood.

    Voir plus Voir moins
    19 min
  • Special Episode: Maternal Health in Hematology
    Dec 5 2025

    In this special episode, Blood editor Dr. Laura Michaelis interviews Dr. Arielle Langer and Blood Associate editor Dr. Marc Blondon for this special Maternal Health episode. In honor of the second Maternal Health compendium, both discuss their papers featured in this special collection.

    Featured Articles:

    • β-Thalassemia minor is associated with high rates of worsening anemia in pregnancy
    • Longitudinal profile of estrogen-related thrombotic biomarkers after cessation of combined hormonal contraceptives

    See the entire Maternal Health Compendium Second Edition

    Voir plus Voir moins
    21 min
  • Analysis of IELSG37 Trial Results and PF4 in Stem Cell Aging
    Dec 4 2025

    In this week's episode, Blood editor Dr. James Griffin speaks with Drs. Emanuele Zucca and Sandra Pinho about their latest articles published in Blood. Dr. Zucca discusses his second analysis of the IELSG37 trial, where findings suggested that R-CHOP21 rituximab, cyclophosphamide,
    doxorubicin, vincristine, and prednisone, administered every 21 days) may be a suboptimal frontline regimen for PMBCL. Dr. Pinho discusses the aging megakaryocytic niche and its influence on the age-associated decline in HSC and progenitor cell function. The authors demonstrate that remodeling of the megakaryocytic niche and associated platelet factor 4 (PF4) downregulation are central mechanisms driving HSC aging.

    Featured Articles:

    • Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial
    • Platelet Factor 4 (PF4) Regulates Hematopoietic Stem Cell Aging
    Voir plus Voir moins
    16 min
Pas encore de commentaire